Practical, evidence-based ways to manage prostate cancer: how surveillance, surgery, radiation, systemic drugs, lifestyle, and mental-health support fit together.
A concise, updated overview of prostate anatomy, detection (PSA and DRE), treatment options from active surveillance to surgery, radiation, hormone therapies, and newer targeted options for advanced disease.
Prostate cancer treatment is individualized by stage and risk. Early disease may be monitored with active surveillance or treated with surgery or radiation. Advanced disease relies on androgen-deprivation, systemic targeted agents, chemotherapy, and radioligand therapy, with decisions guided by biomarkers and patient goals.
Selecting prostate cancer treatment in 2025 means balancing tumor risk, life expectancy, and personal priorities - active surveillance is standard for many low-risk cases, while surgery, radiation, and systemic therapies remain options for higher-risk disease.
Practical, evidence-minded steps to lower prostate cancer risk: focus on a plant-forward diet, healthy weight, regular activity, avoid unproven supplements, and use shared decision-making for PSA screening.
Prostate problems - including BPH, prostatitis, and prostate cancer - become more common with age. Today men choose among three broad approaches: monitoring, medication, or procedures/surgery. This update explains current options, what works, and when to act.
The PSA blood test detects prostate-specific antigen, which can be elevated for reasons besides cancer. Use PSA results with exam findings, risk factors, and additional tests. Screening involves trade-offs - benefits of early detection versus risks of overdiagnosis and biopsy complications - so discuss options with your clinician.